UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Plasminogen activator inhibitor‐1, inflammation, obesity, insulin resistance and vascular risk

Journal of thrombosis and haemostasis, 2003-07, Vol.1 (7), p.1575-1579

2003

Volltextzugriff (PDF)

C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet

Diabetologia, 2007-06, Vol.50 (6), p.1267-1276

2007

Volltextzugriff (PDF)

Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease

Diabetes (New York, N.Y.), 1997-05, Vol.46 (5), p.860-867

1997

Volltextzugriff (PDF)

On the role of plasminogen activator inhibitor‐1 in adipose tissue development and insulin resistance in mice

Journal of thrombosis and haemostasis, 2005-06, Vol.3 (6), p.1174-1179

2005

Volltextzugriff (PDF)

Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease

Diabetes (New York, N.Y.), 1997-05, Vol.46 (5), p.860-867

1997

Volltextzugriff (PDF)

Adipocytokines and the risk of coronary heart disease in healthy middle aged men: the PRIME Study

International Journal of Obesity, 2010-01, Vol.34 (1), p.118-126

2010

Volltextzugriff (PDF)

Activated thrombin activatable fibrinolysis inhibitor levels are associated with the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study

Journal of thrombosis and haemostasis, 2009-01, Vol.7 (1), p.49-57

2009

Volltextzugriff (PDF)

Prothrombin G20210A carriers the genetic mutation and a history of venous thrombosis contributes to thrombin generation independently of factor II plasma levels

Journal of thrombosis and haemostasis, 2010-05, Vol.8 (5), p.942-949

2010

Volltextzugriff (PDF)

Polymorphisms of the tumor necrosis factor-alpha (TNF) and the TNF-alpha converting enzyme (TACE/ADAM17) genes in relation to cardiovascular mortality: the AtheroGene study

Journal of molecular medicine (Berlin, Germany), 2008-10, Vol.86 (10), p.1153-1161

2008

Volltextzugriff (PDF)

Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and south of Europe

Arteriosclerosis, thrombosis, and vascular biology, 2002-05, Vol.22 (5), p.867-873

2002

Volltextzugriff (PDF)

Prognostic value of plasma tissue factor and tissue factor pathway inhibitor for cardiovascular death in patients with coronary artery disease: the AtheroGene study

Journal of thrombosis and haemostasis, 2007-03, Vol.5 (3), p.475-482

2007

Volltextzugriff (PDF)

Influence of PAI-1 on adipose tissue growth and metabolic parameters in a murine model of diet-induced obesity

Arteriosclerosis, thrombosis, and vascular biology, 2000-04, Vol.20 (4), p.1150-1154

2000

Volltextzugriff (PDF)

TAFI gene haplotypes, TAFI plasma levels and future risk of coronary heart disease: the PRIME Study

Journal of thrombosis and haemostasis, 2005-07, Vol.3 (7), p.1503-1510

2005

Volltextzugriff (PDF)

Plasma TAFI antigen variations in healthy subjects

Thrombosis and haemostasis, 2000-06, Vol.83 (6), p.902-905

2000

Volltextzugriff (PDF)

Hypofibrinolysis in the insulin resistance syndrome: implication in cardiovascular diseases

Journal of internal medicine, 2004-04, Vol.255 (4), p.448-456

2004

Volltextzugriff (PDF)

Thrombin-activatable fibrinolysis inhibitor antigen levels and cardiovascular risk factors

Arteriosclerosis, thrombosis, and vascular biology, 2000-09, Vol.20 (9), p.2156-2161

2000

Volltextzugriff (PDF)

Protein Z plasma levels are not associated with the risk of coronary heart disease: the PRIME Study

Journal of thrombosis and haemostasis, 2004-11, Vol.2 (11), p.2050-2051

2004

Volltextzugriff (PDF)

Contribution of novel biomarkers to incident stable angina and acute coronary syndrome: the PRIME Study

European heart journal, 2008-08, Vol.29 (16), p.1966-1974

2008

Volltextzugriff (PDF)

Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis

Diabetologia, 1991-07, Vol.34 (7), p.457-462

1991

Volltextzugriff (PDF)

Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy european men : The prospective epidemiological study of myocardial infarction (PRIME)

Circulation (New York, N.Y.), 2005-05, Vol.111 (18), p.2299-2305

2005

Volltextzugriff (PDF)

Very high TAFI antigen levels are associated with a lower risk of hard coronary events: the PRIME Study

Journal of thrombosis and haemostasis, 2003-10, Vol.1 (10), p.2243-2244

2003

Volltextzugriff (PDF)

Weak and non‐independent association between plasma TAFI antigen levels and the insulin resistance syndrome

Journal of thrombosis and haemostasis, 2003-04, Vol.1 (4), p.791-797

2003

Volltextzugriff (PDF)

PAI-1 produced ex vivo by human adipose tissue is relevant to PAI-1 blood level

Arteriosclerosis, thrombosis, and vascular biology, 1999-05, Vol.19 (5), p.1361-1365

1999

Volltextzugriff (PDF)

Chronic plasminogen activator inhibitor‐1 (PAI‐1) overexpression dampens CD25+ lymphocyte recruitment after lipopolysaccharide endotoxemia in mouse lung

Journal of thrombosis and haemostasis, 2007-12, Vol.5 (12), p.2467-2475

2007

Volltextzugriff (PDF)

Visceral fat as a main determinant of plasminogen activator inhibitor 1 level in women

International Journal of Obesity, 1998-04, Vol.22 (4), p.312-317

1998

Volltextzugriff (PDF)

1 – 25 von 1.902

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.435)
Mit Volltextzugriff
(1.387)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

6 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(956)
Life Sciences & Biomedicine
(633)
Humans
(541)
Male
(311)
Female
(272)
Biological And Medical Sciences
(241)
Physical Sciences
(238)
Middle Aged
(220)
Medical Sciences
(189)
Adult
(184)
Cardiovascular System & Cardiology
(169)
Technology
(158)
Peripheral Vascular Disease
(150)
Hematology
(140)
Animals
(133)
Aged
(124)
Astronomy & Astrophysics
(112)
Risk Factors
(104)
Engineering
(92)
Adolescent
(69)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Plasminogen activator inhibitor‐1, inflammation, obesity, insulin resistance and vascular risk

C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet

Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease

On the role of plasminogen activator inhibitor‐1 in adipose tissue development and insulin resistance in mice

Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease

Adipocytokines and the risk of coronary heart disease in healthy middle aged men: the PRIME Study

Activated thrombin activatable fibrinolysis inhibitor levels are associated with the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study

Prothrombin G20210A carriers the genetic mutation and a history of venous thrombosis contributes to thrombin generation independently of factor II plasma levels

Polymorphisms of the tumor necrosis factor-alpha (TNF) and the TNF-alpha converting enzyme (TACE/ADAM17) genes in relation to cardiovascular mortality: the AtheroGene study

Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and south of Europe

Prognostic value of plasma tissue factor and tissue factor pathway inhibitor for cardiovascular death in patients with coronary artery disease: the AtheroGene study

Influence of PAI-1 on adipose tissue growth and metabolic parameters in a murine model of diet-induced obesity

TAFI gene haplotypes, TAFI plasma levels and future risk of coronary heart disease: the PRIME Study

Plasma TAFI antigen variations in healthy subjects

Hypofibrinolysis in the insulin resistance syndrome: implication in cardiovascular diseases

Thrombin-activatable fibrinolysis inhibitor antigen levels and cardiovascular risk factors

Protein Z plasma levels are not associated with the risk of coronary heart disease: the PRIME Study

Contribution of novel biomarkers to incident stable angina and acute coronary syndrome: the PRIME Study

Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis

Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy european men : The prospective epidemiological study of myocardial infarction (PRIME)

Very high TAFI antigen levels are associated with a lower risk of hard coronary events: the PRIME Study

Weak and non‐independent association between plasma TAFI antigen levels and the insulin resistance syndrome

PAI-1 produced ex vivo by human adipose tissue is relevant to PAI-1 blood level

Chronic plasminogen activator inhibitor‐1 (PAI‐1) overexpression dampens CD25+ lymphocyte recruitment after lipopolysaccharide endotoxemia in mouse lung

Visceral fat as a main determinant of plasminogen activator inhibitor 1 level in women

Suchergebnisse filtern